Pacira BioSciences, Inc. (PCRX) NASDAQ

23.90

+0.42(+1.79%)

Updated at June 30 04:00PM

Currency In USD

Valuation

Market Cap871.26M
Enterprise Value1.23B
P/E Ratio-10.66
PEG Ratio2.56
Price/Sales Ratio1.57
Price/Book Ratio1.38
Enterprise/Revenue2.08
Enterprise/EBITDA72.46

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-0.15
Operating Margin-0.12

Management Effectiveness

Return On Assets-0.07
Return On Equity-0.13

Income Statement

Revenue700.97M
Revenue/Share15.19
Gross Profit530.54M
EBITDA32.25M
Net Income-99.56M
Diluted EPS-2.15

Balance Sheet

Total Cash493.63M
Total Cash/Share10.67
Total Debt636.46M
Total Debt/Equity0.8
Current Ratio2.41
Book Value Per Share17.26

Price History

52-Week Change-16.02
52-Week High29.33
52-Week Low11.16
Moving Average 50 Days25.39
Moving Average 200 Days21.55

Statistics

Average Volume809,890
Shares Outstanding46.3M
% Held by Institutions109.12

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A